Published in J Pharm Sci on November 01, 1998
Nanogels for oligonucleotide delivery to the brain. Bioconjug Chem (2004) 1.94
Blood-brain barrier transport of therapeutics via receptor-mediation. Pharm Res (2007) 1.54
Brain tumor tandem targeting using a combination of monoclonal antibodies attached to biopoly(beta-L-malic acid). J Control Release (2007) 1.13
New technologies for drug delivery across the blood brain barrier. Curr Pharm Des (2004) 0.89
Conformation of oligodeoxynucleotides associated with anionic liposomes. Nucleic Acids Res (2000) 0.88
Lipid peptide nanocomplexes for gene delivery and magnetic resonance imaging in the brain. J Control Release (2012) 0.85
Smuggling Drugs into the Brain: An Overview of Ligands Targeting Transcytosis for Drug Delivery across the Blood-Brain Barrier. Pharmaceutics (2014) 0.83
Nanoparticle for delivery of antisense γPNA oligomers targeting CCR5. Artif DNA PNA XNA (2013) 0.80
Designing Second Generation Anti-Alzheimer Compounds as Inhibitors of Human Acetylcholinesterase: Computational Screening of Synthetic Molecules and Dietary Phytochemicals. PLoS One (2015) 0.75
Mutation of DNASE1 in people with systemic lupus erythematosus. Nat Genet (2001) 3.21
Peroxisome proliferator-activated receptors and hepatic stellate cell activation. J Biol Chem (2000) 2.58
Brain metabolism: a perspective from the blood-brain barrier. Physiol Rev (1983) 2.46
Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins. J Neurochem (1990) 2.45
Analgesic effect of morphine glucuronides. Tohoku J Exp Med (1971) 2.02
Selective expression of the large neutral amino acid transporter at the blood-brain barrier. Proc Natl Acad Sci U S A (1999) 1.93
Brain drug delivery of small molecules using immunoliposomes. Proc Natl Acad Sci U S A (1996) 1.91
Transport of metabolic substrates through the blood-brain barrier. J Neurochem (1977) 1.73
Exacerbation of alcoholic liver injury by enteral endotoxin in rats. Hepatology (2000) 1.73
Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion. Eye (Lond) (2006) 1.73
Ethanol diet increases the sensitivity of rats to pancreatitis induced by cholecystokinin octapeptide. Gastroenterology (1999) 1.71
Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor beta: implication for a pathogenetic role in alcoholic liver fibrogenesis. Hepatology (1990) 1.68
Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse. J Pharmacol Exp Ther (2000) 1.63
Thyroid function in nonthyroidal illnesses. Ann Intern Med (1983) 1.62
Delivery of peptides and proteins through the blood-brain barrier. Adv Drug Deliv Rev (2001) 1.62
Immunohistochemical study of cerebral amyloid angiopathy. III. Widespread Alzheimer A4 peptide in cerebral microvessel walls colocalizes with gamma trace in patients with leukoencephalopathy. Ann Neurol (1990) 1.57
Mediated efflux of IgG molecules from brain to blood across the blood-brain barrier. J Neuroimmunol (2001) 1.52
Human blood-brain barrier transferrin receptor. Metabolism (1987) 1.50
Ethanol-induced liver fibrosis in rats fed high fat diet. Hepatology (1986) 1.48
Changes in methionine adenosyltransferase and S-adenosylmethionine homeostasis in alcoholic rat liver. Am J Physiol Gastrointest Liver Physiol (2000) 1.48
Human blood-brain barrier insulin receptor. J Neurochem (1985) 1.47
Glucose transport and phosphorylation: which is rate limiting for brain glucose utilization? Ann Neurol (1994) 1.46
Three distinct forms of type 2A protein phosphatase in human erythrocyte cytosol. J Biol Chem (1988) 1.45
Vitamin C crosses the blood-brain barrier in the oxidized form through the glucose transporters. J Clin Invest (1997) 1.43
Absorptive-mediated endocytosis of cationized albumin and a beta-endorphin-cationized albumin chimeric peptide by isolated brain capillaries. Model system of blood-brain barrier transport. J Biol Chem (1987) 1.42
Noninvasive gene targeting to the brain. Proc Natl Acad Sci U S A (2000) 1.42
Transport of steroid hormones through the rat blood-brain barrier. Primary role of albumin-bound hormone. J Clin Invest (1979) 1.42
Relationship between thromboxane/prostacyclin ratio and diabetic vascular complications. Prostaglandins Leukot Essent Fatty Acids (2001) 1.42
Blood-brain barrier transcytosis of insulin in developing rabbits. Brain Res (1987) 1.42
Bioavailable testosterone in salivary glands. Clin Chem (1991) 1.39
Blood-brain barrier transport of cationized immunoglobulin G: enhanced delivery compared to native protein. Proc Natl Acad Sci U S A (1989) 1.39
Human blood-brain barrier leptin receptor. Binding and endocytosis in isolated human brain microvessels. J Clin Invest (1997) 1.37
Molecular cloning and expression of cDNA for murine galactocerebrosidase and mutation analysis of the twitcher mouse, a model of Krabbe's disease. J Neurochem (1996) 1.37
Receptor-mediated peptide transport through the blood-brain barrier. Endocr Rev (1986) 1.35
Expression of intracellular adhesion molecule 1 by activated hepatic stellate cells. Hepatology (1996) 1.35
Severe and progressive steatosis and focal necrosis in rat liver induced by continuous intragastric infusion of ethanol and low fat diet. Hepatology (1985) 1.33
Expression of interleukin-10 by in vitro and in vivo activated hepatic stellate cells. J Biol Chem (1998) 1.33
Kinetics of blood-brain barrier transport of pyruvate, lactate and glucose in suckling, weanling and adult rats. J Neurochem (1979) 1.33
Kinetics of blood-brain transport of hexoses. Biochim Biophys Acta (1975) 1.32
Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor. Pharm Res (2000) 1.31
Cyclical pattern of blood alcohol levels during continuous intragastric ethanol infusion in rats. Alcohol Clin Exp Res (1985) 1.28
Role of iron in NF-kappa B activation and cytokine gene expression by rat hepatic macrophages. Am J Physiol (1997) 1.24
Blood-brain barrier glucose transporter is asymmetrically distributed on brain capillary endothelial lumenal and ablumenal membranes: an electron microscopic immunogold study. Proc Natl Acad Sci U S A (1991) 1.24
Metabolism of drugs. LIX. A new metabolite of antipyrine. Biochem Pharmacol (1968) 1.23
Structure of serum transferrin in carbohydrate-deficient glycoprotein syndrome. Biochem Biophys Res Commun (1992) 1.23
Role of cytochrome P-450 2E1 in ethanol-, carbon tetrachloride- and iron-dependent microsomal lipid peroxidation. Hepatology (1992) 1.22
Gene expression of GLUT3 and GLUT1 glucose transporters in human brain tumors. Brain Res Mol Brain Res (1994) 1.20
Mitochondrial glutathione depletion in alcoholic liver disease. Alcohol (1994) 1.20
hnRNP A2 and hnRNP L bind the 3'UTR of glucose transporter 1 mRNA and exist as a complex in vivo. Biochem Biophys Res Commun (1999) 1.19
Neuroprotection with noninvasive neurotrophin delivery to the brain. Proc Natl Acad Sci U S A (1999) 1.19
Isolation and properties of suppressor-sensitive mutants of Bacillus subtilis bacteriophage SP02. J Virol (1970) 1.18
Metabolism of drugs. LXX. Further study on antipyrine metabolism. Chem Pharm Bull (Tokyo) (1971) 1.17
Kinetics of competitive inhibition of neutral amino acid transport across the blood-brain barrier. J Neurochem (1977) 1.16
Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease. Hepatology (1995) 1.16
Long-term cannulation model for blood sampling and intragastric infusion in the rat. Am J Physiol (1984) 1.15
Brain-specific expression of an exogenous gene after i.v. administration. Proc Natl Acad Sci U S A (2001) 1.15
Increased 4-hydroxynonenal levels in experimental alcoholic liver disease: association of lipid peroxidation with liver fibrogenesis. Hepatology (1992) 1.14
Transport of protein-bound hormones into tissues in vivo. Endocr Rev (1981) 1.12
GLUT1 glucose transporter expression in the diabetic and nondiabetic human eye. Invest Ophthalmol Vis Sci (1994) 1.12
Blood-brain barrier genomics. J Cereb Blood Flow Metab (2001) 1.11
Kinetic analysis of blood-brain barrier transport of amino acids. Biochim Biophys Acta (1975) 1.11
High molecular weight Alzheimer's disease amyloid peptide immunoreactivity in human serum and CSF is an immunoglobulin G. Biochem Biophys Res Commun (1987) 1.11
Wnt signaling regulates hemopoiesis through stromal cells. J Immunol (2001) 1.11
Upregulation of blood-brain barrier GLUT1 glucose transporter protein and mRNA in experimental chronic hypoglycemia. Diabetes (1995) 1.11
Outside-to-inside signal through the membrane TNF-alpha induces E-selectin (CD62E) expression on activated human CD4+ T cells. J Immunol (2001) 1.10
Association of tumor necrosis factor receptor type II polymorphism 196R with Systemic lupus erythematosus in the Japanese: molecular and functional analysis. Arthritis Rheum (2001) 1.10
Rapid transferrin efflux from brain to blood across the blood-brain barrier. J Neurochem (2001) 1.10
Bioavailability of albumin-bound testosterone. J Clin Endocrinol Metab (1985) 1.10
Brain amyloid and Alzheimer disease. Ann Intern Med (1988) 1.10
Does gastrojejunostomy for unresectable cancer of the gastric antrum offer satisfactory palliation? Hepatogastroenterology (1999) 1.10
Vector-mediated delivery of 125I-labeled beta-amyloid peptide A beta 1-40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the A beta 1-40/vector complex. Proc Natl Acad Sci U S A (1995) 1.10
Transport of [125I]transferrin through the rat blood-brain barrier. Brain Res (1995) 1.08
Association of polymorphisms in complement component C3 gene with susceptibility to systemic lupus erythematosus. Rheumatology (Oxford) (2008) 1.08
Blood-brain barrier permeability to morphine-6-glucuronide is markedly reduced compared with morphine. Drug Metab Dispos (1997) 1.08
Carrier-mediated transport of thyroid hormones through the rat blood-brain barrier: primary role of albumin-bound hormone. Endocrinology (1979) 1.06
Ethanol-induced hepatic fibrosis in the rat: role of the amount of dietary fat. Alcohol Clin Exp Res (1986) 1.06
Immunoreactive A4 and gamma-trace peptide colocalization in amyloidotic arteriolar lesions in brains of patients with Alzheimer's disease. Am J Pathol (1990) 1.06
Human blood-brain barrier insulin-like growth factor receptor. Metabolism (1988) 1.05
Pharmacokinetics and delivery of tat and tat-protein conjugates to tissues in vivo. Bioconjug Chem (2001) 1.04
Serum bioavailability of sex steroid hormones. Clin Endocrinol Metab (1986) 1.04
A dose-escalation study of rituximab for treatment of systemic lupus erythematosus and Evans' syndrome: immunological analysis of B cells, T cells and cytokines. Rheumatology (Oxford) (2008) 1.04
Raised serum APRIL levels in patients with systemic lupus erythematosus. Ann Rheum Dis (2004) 1.04
A case of chronic infantile type of fucosidosis: clinical and magnetic resonance image findings. Brain Dev (2000) 1.04
Up-regulation of blood-brain barrier short-form leptin receptor gene products in rats fed a high fat diet. J Neurochem (1998) 1.03
Blood-brain barrier transport of neuropeptides: analysis with a metabolically stable dermorphin analogue. Am J Physiol (1994) 1.03
Hepatic mitochondrial glutathione depletion and progression of experimental alcoholic liver disease in rats. Hepatology (1992) 1.03
Mitochondrial tRNA(Ile) mutation in fatal cardiomyopathy. Biochem Biophys Res Commun (1992) 1.03
Receptor-mediated gene targeting to tissues in vivo following intravenous administration of pegylated immunoliposomes. Pharm Res (2001) 1.03
Diminished retinoic acid signaling in hepatic stellate cells in cholestatic liver fibrosis. Am J Physiol (1997) 1.03
Simultaneous quantification of prostaglandins in human synovial cell-cultured medium using liquid chromatography/tandem mass spectrometry. Prostaglandins Leukot Essent Fatty Acids (2002) 1.02
Imaging brain tumors by targeting peptide radiopharmaceuticals through the blood-brain barrier. Cancer Res (1999) 1.02
Effect of thioacetamide on the hepatic expression of gamma-glutamylcysteine synthetase subunits in the Rat. Toxicol Appl Pharmacol (1999) 1.02
P-Glycoprotein on astrocyte foot processes of unfixed isolated human brain capillaries. Brain Res (1999) 1.01
Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery. Proc Natl Acad Sci U S A (1993) 1.01
Identification of the 150-kDa surface antigen of Entamoeba histolytica as a galactose- and N-acetyl-D-galactosamine-inhibitable lectin. Parasitol Res (1998) 1.01
Arachidonate 12-lipoxygenase is localized in neurons, glial cells, and endothelial cells of the canine brain. J Histochem Cytochem (1993) 1.01